|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002844,
umls-concept:C0032246,
umls-concept:C0279025,
umls-concept:C0332206,
umls-concept:C0376358,
umls-concept:C0439810,
umls-concept:C0442967,
umls-concept:C0871261,
umls-concept:C0936012,
umls-concept:C1514695,
umls-concept:C1522449,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-3-28
|
|
pubmed:abstractText |
DNA ploidy has consistently been found to be a correlate of prostate cancer patient outcome. However, a minority of studies have used pretreatment diagnostic material and have involved radiotherapy (RT)-treated patients. In this retrospective study, the predictive value of DNA ploidy was evaluated in patients entered into Radiation Therapy Oncology Group protocol 8610. The protocol treatment randomization was RT alone versus RT plus short-course (approximately 4 months) neoadjuvant and concurrent total androgen blockade (RT+TAB).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1238-48
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12663710-Aged,
pubmed-meshheading:12663710-Aged, 80 and over,
pubmed-meshheading:12663710-Androgen Antagonists,
pubmed-meshheading:12663710-Combined Modality Therapy,
pubmed-meshheading:12663710-DNA, Neoplasm,
pubmed-meshheading:12663710-Diploidy,
pubmed-meshheading:12663710-Flutamide,
pubmed-meshheading:12663710-Goserelin,
pubmed-meshheading:12663710-Humans,
pubmed-meshheading:12663710-Male,
pubmed-meshheading:12663710-Middle Aged,
pubmed-meshheading:12663710-Neoplasm Metastasis,
pubmed-meshheading:12663710-Prognosis,
pubmed-meshheading:12663710-Proportional Hazards Models,
pubmed-meshheading:12663710-Prostatic Neoplasms,
pubmed-meshheading:12663710-Retrospective Studies,
pubmed-meshheading:12663710-Salvage Therapy,
pubmed-meshheading:12663710-Survival Rate
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Fox Chase Cancer Center, and Radiation Therapy Oncology Group, Philadelphia, PA 19111, USA. A_Pollack@FCCC.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
